Bioverge Funds, HepaTx I, LLC

New Filing

CIK: 0001863964·Investing·IDAHO·Filed: May 24, 2021

Total Offering

$150,000

Amount Sold

$128,436

Investors

10

First Sale

May 20, 2021

Offering Details

Type: Pooled Investment Fund
Exemptions: Rule 506(b)
Entity Type: Limited Liability Company
Year Incorporated: 2020
Non-Accredited Investors: No

Related Persons

Name	Role
Neil Bioverge Funds Management,LLC - Littman	Related Person

Company

Bioverge Funds, HepaTx I, LLC

222 N 13TH ST.

BOISE, ID, 83702

2086961262

SEC Filing

0001863964-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.